86 related articles for article (PubMed ID: 19646396)
1. CK20/CK7 protein expression in colorectal cancer: a marker for progression of colorectal cancer.
Bressenot A; Zimmer O
Hum Pathol; 2008 Nov; 39(11):1714; author reply 1715. PubMed ID: 19646396
[No Abstract] [Full Text] [Related]
2. CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray.
Hernandez BY; Frierson HF; Moskaluk CA; Li YJ; Clegg L; Cote TR; McCusker ME; Hankey BF; Edwards BK; Goodman MT
Hum Pathol; 2005 Mar; 36(3):275-81. PubMed ID: 15791572
[TBL] [Abstract][Full Text] [Related]
3. Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas.
Bayrak R; Yenidünya S; Haltas H
Pathol Res Pract; 2011 Mar; 207(3):156-60. PubMed ID: 21282015
[TBL] [Abstract][Full Text] [Related]
4. Aberrant pattern of the cytokeratin 7/cytokeratin 20 immunophenotype in colorectal adenocarcinomas with BRAF mutations.
Gurzu S; Jung I
Pathol Res Pract; 2012 Mar; 208(3):163-6. PubMed ID: 22361037
[TBL] [Abstract][Full Text] [Related]
5. Combined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer.
Ikeda S; Fujimori M; Shibata S; Okajima M; Ishizaki Y; Kurihara T; Miyata Y; Iseki M; Shimizu Y; Tokumoto N; Ozaki S; Asahara T
BMC Cancer; 2006 Feb; 6():31. PubMed ID: 16451736
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological implications of positive CK7 expression in colorectal carcinoma].
Yu L; Ding YQ; Xiao S; Lai FJ; Lu X
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1190-2. PubMed ID: 17715023
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis.
Stenling R; Lindberg J; Rutegård J; Palmqvist R
APMIS; 2007 Nov; 115(11):1219-26. PubMed ID: 18092953
[TBL] [Abstract][Full Text] [Related]
8. The role of SATB2 as a diagnostic marker for tumors of colorectal origin: Results of a pathology-based clinical prospective study.
Dragomir A; de Wit M; Johansson C; Uhlen M; Pontén F
Am J Clin Pathol; 2014 May; 141(5):630-8. PubMed ID: 24713733
[TBL] [Abstract][Full Text] [Related]
9. Breast metastases from colorectal carcinoma.
Mihai R; Christie-Brown J; Bristol J
Breast; 2004 Apr; 13(2):155-8. PubMed ID: 15019699
[TBL] [Abstract][Full Text] [Related]
10. Re. article entitled 'Keratin 20 is a specific marker of submicroscopic lymph node metastases in colorectal cancer: validation by K-RAS mutations'.
Harnden P
J Pathol; 2000 Dec; 192(4):560-1. PubMed ID: 11113877
[No Abstract] [Full Text] [Related]
11. Merkel cell carcinomas with CK20 negative and CK7 positive immunostaining.
Beer TW
J Cutan Pathol; 2009 Mar; 36(3):385-6; author reply 387. PubMed ID: 19220637
[No Abstract] [Full Text] [Related]
12. [Tissue microarray (TMA) validated progression markers in colorectal cancer using antibody microarrays].
Spisák S; Galamb B; Wichmann B; Sipos F; Galamb O; Solymosi N; Nemes B; Tulassay Z; Molnár B
Orv Hetil; 2009 Aug; 150(34):1607-13. PubMed ID: 19648079
[TBL] [Abstract][Full Text] [Related]
13. Female urethral adenocarcinoma with a heterogeneous phenotype.
Kuroda N; Shiotsu T; Ohara M; Hirouchi T; Mizuno K; Miyazaki E
APMIS; 2006 Apr; 114(4):314-8. PubMed ID: 16689832
[TBL] [Abstract][Full Text] [Related]
14. An approach to interpreting immunohistochemical stains of adenocarcinoma in small needle core biopsy specimens: the impact of limited specimen size.
Goldstein NS; Bosler D
Am J Clin Pathol; 2007 Feb; 127(2):273-81. PubMed ID: 17210515
[TBL] [Abstract][Full Text] [Related]
15. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells.
van der Flier LG; Haegebarth A; Stange DE; van de Wetering M; Clevers H
Gastroenterology; 2009 Jul; 137(1):15-7. PubMed ID: 19450592
[No Abstract] [Full Text] [Related]
16. Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma.
Ren DN; Kim IY; Koh SB; Chang SJ; Eom M; Yi SY; Seong SH; Kim MD; Bronner MP; Cho MY
J Surg Oncol; 2009 Dec; 100(7):546-52. PubMed ID: 19722231
[TBL] [Abstract][Full Text] [Related]
17. Specificity of intra-acinar necrosis as a marker of colorectal liver metastasis.
Wong NA; Neville LP
Histopathology; 2007 Nov; 51(5):725-7. PubMed ID: 17927604
[No Abstract] [Full Text] [Related]
18. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
[TBL] [Abstract][Full Text] [Related]
19. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
[TBL] [Abstract][Full Text] [Related]
20. Serum p53 antibodies as an early detection marker in colorectal cancer.
Takeda A; Shimadai H; Iseki H; Saeki T; Koyama I
Hepatogastroenterology; 2007 Sep; 54(78):2 pages preceeding table of content. PubMed ID: 18019675
[No Abstract] [Full Text] [Related]
[Next] [New Search]
